FDA OKs Blood Test for Heart Disease Risk
Posted on: Sunday, 20 July 2003, 06:00 CDT
WASHINGTON (AP) - Doctors are getting a new blood test to help predict which people with low cholesterol are at risk for heart disease.
The Food and Drug Administration approved the PLAC test Friday. It works by measuring an enzyme active in the inflammatory process, one known as Lp-PLA2.
In a federally financed study, researchers tracked more than 1,300 middle-aged people for nine years to see who was most at risk of developing heart disease.
Of most interest were people considered at very low risk of heart disease because they had normal levels of the so-called bad cholesterol, or LDL cholesterol - levels below 130.
When those low-cholesterol patients had high levels of Lp-PLA2, however, they were twice as likely to develop heart disease, said lead researcher Dr. Christie Ballantyne of Baylor College of Medicine.
Add another measure of risk - a separate inflammatory protein called C-reactive protein - to a high Lp-PLA2 level, and the risk of heart disease tripled, he said.
Between one-third and half of heart attacks occur in people who do not have high cholesterol, so scientists have long hunted ways to find which of those people were at risk in time to help them.
The PLAC test promises to be one tool to do that, Ballantyne said.
The laboratory test is made by diaDexus Inc. of San Francisco. The company wouldn't reveal a price but said it would be competitive with testing for C-reative protein, which is roughly $16.
-----
On the Net:
U.S. Food and Drug Administration
More science, space, and technology from RedNova
Copyright © 2003 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten or redistributed without the prior written authority of The Associated Press.
Related Articles
- Statins Cannot Erode Heart Attack Risks Caused by Low Levels of Good Cholesterol
- Study Links Heart Disease Deaths With High Lead Levels In Blood
- VAP Cholesterol Test Helps In Search For New Heart Disease Drugs
- Heart Disease Blood Test May Predict Risk
- Study: Drug Underprescribed Cholesterol-Lowering Statins Not Getting to at-Risk Heart Disease Patients
- New One-A-Day Cholesterol Plus With Policosanol is First Leading Multivitamin to Maintain Healthy Cholesterol and Blood Pressure Levels -
- Lipitor Patients Who Reduced 'Bad' Cholesterol To Very Low Levels Show Significant Decrease in Heart Attack and Stroke, New Data Show
- A Randomized Trial of a Strategy for Increasing High-Density Lipoprotein Cholesterol Levels: Effects on Progression of Coronary Heart Disease and Clinical Events
- Debating a Link to Heart Disease Does Reducing a Protein's Level Reduce the Risk of Attack?
 |
 |
User Comments (0)
RSS Feeds